3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
15
Neoplasm Metastasis
11
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Stomach Neoplasms
6
Skin Neoplasms
6
Leukemia, Myeloid, Acute
6
Colorectal Neoplasms
6
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
4
Gastrointestinal Neoplasms
4
Breast Neoplasms
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urogenital Neoplasms
3
Rectal Neoplasms
3
Neuroblastoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia
3
Colonic Neoplasms
3
Vaginal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Penile Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Interventions
Magnetic Resonance Spectroscopy
10
trametinib
7
Nivolumab
7
selpercatinib
6
pembrolizumab
6
dabrafenib
6
Iodine-131
6
Specimen Handling
5
Biopsy
5
lenvatinib
4
Vemurafenib
4
Iodine-124
4
durvalumab
3
cabozantinib
3
binimetinib
3
Ipilimumab
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
Disulfides
3
Cyclophosphamide
3
Cetuximab
3
vandetanib
2
ulixertinib
2
omipalisib
2
larotrectinib
2
defactinib
2
copanlisib
2
cemiplimab
2
anlotinib
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
aldesleukin
×
1 year
×
Clear all
No trials found.